235 related articles for article (PubMed ID: 37186587)
1. Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma.
Sossa-Rojas H; Franco-Maz PG; Zapata-Acevedo C; Gutierrez-Castañeda LD; Guerrero C
PLoS One; 2023; 18(5):e0285543. PubMed ID: 37186587
[TBL] [Abstract][Full Text] [Related]
2. Assessing the oncolytic potential of rotavirus on mouse myeloma cell line Sp2/0-Ag14.
Guerrero RA; Guerrero CA; Guzmán F; Acosta O
Biomedica; 2020 Jun; 40(2):362-381. PubMed ID: 32673463
[TBL] [Abstract][Full Text] [Related]
3. Role of heat-shock proteins in infection of human adenocarcinoma cell line MCF-7 by tumor-adapted rotavirus isolates.
Perez C; Rico J; Guerrero C; Acosta O
Colomb Med (Cali); 2021 Mar; 52(1):e2024196. PubMed ID: 33911319
[TBL] [Abstract][Full Text] [Related]
4. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
5. Induction of Cell Death in the Human Acute Lymphoblastic Leukemia Cell Line Reh by Infection with Rotavirus Isolate Wt1-5.
Guerrero R; Guerrero C; Acosta O
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32722005
[TBL] [Abstract][Full Text] [Related]
6. Implication of heat shock proteins in rotavirus entry into Reh cells.
Rico J; Perez C; Guerrero R; Hernandez J; Guerrero C; Acosta O
Acta Virol; 2020; 64(4):433-450. PubMed ID: 33112641
[TBL] [Abstract][Full Text] [Related]
7. Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.
Wang W; Ji W; Hu H; Ma J; Li X; Mei W; Xu Y; Hu H; Yan Y; Song Q; Li Z; Su C
Oncotarget; 2014 Jan; 5(1):150-60. PubMed ID: 24473833
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.
Marchica V; Costa F; Donofrio G; Giuliani N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668361
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Suryawanshi YR; Schulze AJ
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
[TBL] [Abstract][Full Text] [Related]
13. Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.
Haley ES; Au GG; Carlton BR; Barry RD; Shafren DR
J Mol Med (Berl); 2009 Apr; 87(4):385-99. PubMed ID: 19139835
[TBL] [Abstract][Full Text] [Related]
14. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
[TBL] [Abstract][Full Text] [Related]
15. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment.
Ghasemi Darestani N; Gilmanova AI; Al-Gazally ME; Zekiy AO; Ansari MJ; Zabibah RS; Jawad MA; Al-Shalah SAJ; Rizaev JA; Alnassar YS; Mohammed NM; Mustafa YF; Darvishi M; Akhavan-Sigari R
Cell Commun Signal; 2023 Feb; 21(1):43. PubMed ID: 36829187
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus as an oncolytic agent.
Ravindra PV; Tiwari AK; Sharma B; Chauhan RS
Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097
[TBL] [Abstract][Full Text] [Related]
18. Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus.
Xia M; Meng G; Jiang A; Chen A; Dahlhaus M; Gonzalez P; Beltinger C; Wei J
Oncotarget; 2014 Jun; 5(11):3907-18. PubMed ID: 25004098
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword.
Blitz SE; Kappel AD; Gessler FA; Klinger NV; Arnaout O; Lu Y; Peruzzi PP; Smith TR; Chiocca EA; Friedman GK; Bernstock JD
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163730
[TBL] [Abstract][Full Text] [Related]
20. Impact of tumor microenvironment on oncolytic viral therapy.
Wojton J; Kaur B
Cytokine Growth Factor Rev; 2010; 21(2-3):127-34. PubMed ID: 20399700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]